Inventor profile of:

Rob de Jong

City:

Utrecht

Country:

Netherlands

Published Applications:

24

Last publication date:

2026-05-14

Top Assignees for applications by Rob de Jong

The entities that hold a legal rights for patent applications filed by inventor de Jong Rob:

Recent patent applications by de Jong Rob

Rob de Jong from Utrecht, NL has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-14
US20260132211A1
Chemistry; metallurgy

ANTIBODY VARIANT COMBINATIONS AND USES THEREOF

#2 | 2026-05-14
US20260132186A1
Chemistry; metallurgy

METHOD FOR PRODUCING A CONTROLLED MIXTURE OF TWO OR MORE DIFFERENT ANTIBODIES

#3 | 2025-10-23
US20250326854A1
Chemistry; metallurgy

POLYPEPTIDE VARIANTS AND USES THEREOF

#4 | 2025-09-04
US20250277040A1
Chemistry; metallurgy

AGENT, USES AND METHODS FOR TREATMENT

#5 | 2023-10-12
US20230321261A1
Human necessities

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT

#6 | 2023-05-25
US20230159643A1
Chemistry; metallurgy

AGENT, USES AND METHODS FOR TREATMENT

#7 | 2023-04-06
US20230107363A1
Chemistry; metallurgy

POLYPEPTIDE VARIANTS AND USES THEREOF

#8 | 2022-12-29
US20220411529A1
Chemistry; metallurgy

ANTIBODY VARIANT COMBINATIONS AND USES THEREOF

#9 | 2022-12-29
US20220411522A1
Chemistry; metallurgy

ANTI-DEATH RECEPTOR ANTIBODIES AND METHODS OF USE THEREOF

#10 | 2022-10-20
US20220332801A1
Chemistry; metallurgy

ANTIBODIES AND METHODS OF USE THEREOF IN TREATMENT OF INFECTIOUS DISEASE

#11 | 2021-09-02
US20210269524A1
Chemistry; metallurgy

Agent, uses and methods for treatment

#12 | 2021-09-02
US20210269509A1
Chemistry; metallurgy

Method for producing a controlled mixture of two or more different antibodies

#13 | 2021-08-05
US20210238296A1
Chemistry; metallurgy

ANTIBODY VARIANT COMBINATIONS AND USES THEREOF

#14 | 2021-04-15
US20210107988A1
Chemistry; metallurgy

POLYPEPTIDE VARIANTS AND USES THEREOF

#15 | 2020-12-24
US20200397913A1
Human necessities

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT

#16 | 2020-06-18
US20200190188A1
Chemistry; metallurgy

Agent, uses and methods for treatment

#17 | 2020-06-11
US20200181277A1
Chemistry; metallurgy

Polypeptide variants and uses thereof

#18 | 2020-04-23
US20200123237A1
Chemistry; metallurgy

ANTIBODIES AND METHODS OF USE THEREOF IN TREATMENT OF INFECTIOUS DISEASE

#19 | 2019-09-12
US20190276549A1
Chemistry; metallurgy

POLYPEPTIDE VARIANTS AND USES THEREOF

#20 | 2019-07-04
US20190202926A1
Chemistry; metallurgy

ANTI-DEATH RECEPTOR ANTIBODIES AND METHODS OF USE THEREOF

#21 | 2019-01-24
US20190022243A1
Human necessities

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT

#22 | 2018-11-15
US20180326084A1
Human necessities

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT

#23 | 2018-10-25
US20180305455A1
Chemistry; metallurgy

Agent, uses and methods for treatment

#24 | 2017-09-21
US20170267761A1
Chemistry; metallurgy

Anti-sortilin antibodies, uses and methods for treatment

InventorID:

1988053 ⎘